Drug Safety

, Volume 22, Issue 6, pp 479–485 | Cite as

Fluoroquinolone-Induced Renal Failure

  • Ben M. LomaestroEmail author
Review Article


Fluoroquinolones are generally well tolerated, clinically useful antimicrobials. This paper highlights rare, but potentially serious, adverse effects involving the kidney. Other antimicrobials have long been known to cause various forms of nephrotoxicity occurring as allergic interstitial nephritis, granulomatous interstitial nephritis, necrotising vasculitis, allergic tubular nephritis or a tubular necrosis. A Medline search (1985 to May 1999) of ciprofloxacin, norfloxacin, levofloxacin, ofloxacin, trovafloxacin, enoxacin, sparfloxacin, grepafloxacin, gatifloxacin, clinafloxacin and moxifloxacin was conducted to ascertain the incidence and features of fluoroquinolone nephrotoxicity. Unfortunately, the data primarily consist of case reports and temporally related events. The incidence of these adverse effects is hard to estimate, and the cause may be multifactorial. While the use of ciprofloxacin appears to increase the risk, this may be due to its longer and more widespread use when compared with the newer agents.


Acute Renal Failure Fluoroquinolones Ofloxacin Levofloxacin Moxifloxacin 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Koren G. The nephrotoxic potential of drugs and chemicals. Pharmacological basis and clinical relevance. Med Toxicol 1989; 4: 59–72Google Scholar
  2. 2.
    Kaloyanides GJ. Antibiotic-related nephrotoxicity. Nephrol Dial Transplant 1994; 9: Suppl. 4: 130–4PubMedGoogle Scholar
  3. 3.
    Godin M, Ducastelle T, Bercoff E, et al. Renal failure and quinolone. Nephron 1984; 37: 70PubMedCrossRefGoogle Scholar
  4. 4.
    Ball P. Ciprofloxacin: an overview of adverse experiences. J Antimicrob Chemother 1986; 18Suppl. D: 187–93PubMedGoogle Scholar
  5. 5.
    Hootkins R, Fenves AZ, Stephens MK. Acute renal failure secondary to oral ciprofloxacin therapy: a presentation of three cases and a review of the literature. Clin Nephrol 1989; 32: 75–8PubMedGoogle Scholar
  6. 6.
    Lien YH, Hansen R, Kern WF, et al. Ciprofloxacin-induced granulomatous interstitial nephritis and localized elastolysis. Am J Kidney Dis 1993; 22: 598–602PubMedGoogle Scholar
  7. 7.
    Ying LS, Johnson CA. Ciprofloxacin induced interstitial nephritis. Clin Pharm 1989; 8: 518–21PubMedGoogle Scholar
  8. 8.
    Murray KM, Wilson MG. Suspected ciprofloxacin-induced allergic interstitial nephritis. DICP 1990; 24: 379–80PubMedGoogle Scholar
  9. 9.
    Reece RJ, Nicholls AJ. Ciprofloxacin-induced acute interstitial nephritis [letter]. Nephrol Dial Transplant 1996; 11: 393PubMedCrossRefGoogle Scholar
  10. 10.
    Helmink R, Benediktsson H. Ciprofloxacin-induced allergic interstitial nephritis [letter]. Nephron 1990; 55: 432–3PubMedCrossRefGoogle Scholar
  11. 11.
    Allon M, Lopez EJ, Min KW. Acute renal failure due to ciprofloxacin. Arch Intern Med 1990; 150: 2187–9PubMedCrossRefGoogle Scholar
  12. 12.
    Ortiz A, Plaza JJ, Egido J. Ciprofloxacin-associated tubulointerstitial nephritis with linear tubular basement membrane deposits [letter]. Nephron 1992; 60: 248PubMedCrossRefGoogle Scholar
  13. 13.
    Lo WK, Rolston KVI, Rubenstein EB, et al. Ciprofloxacininduced nephrotoxicity in patients with cancer. Arch Intern Med 1993; 153: 1258–62PubMedCrossRefGoogle Scholar
  14. 14.
    Rosado LJ, Sisking MS, Copeland JG. Acute interstitial nephritis in a cardiac transplant recipient receiving ciprofloxacin. J Thorac Cardiovasc Surg 1994; 107: 1364–79PubMedGoogle Scholar
  15. 15.
    Shih DJ, Korbet SM, Rydel JJ, et al. Renal vasculitis associated with ciprofloxacin. Am J Kidney Dis 1995; 26: 516–9PubMedCrossRefGoogle Scholar
  16. 16.
    Dharnidharka VR, Nadeau K, Cannon CL, et al. Ciprofloxacin overdose: acute renal failure with prominent apoptotic changes. Am J Kidney Dis 1998; 31: 710–2PubMedCrossRefGoogle Scholar
  17. 17.
    George MJ, Dew RB III, Daly JS. Acute renal failure after an overdose of ciprofloxacin. Arch Intern Med 1991; 151: 620CrossRefGoogle Scholar
  18. 18.
    Avent KC, Krinsky D, Kirklin JK, et al. Synergistic nephrotoxicity due to ciprofloxacin and cyclosporine. Am J Med 1988; 85: 452–3PubMedCrossRefGoogle Scholar
  19. 19.
    Rolston KVI, Rubenstein EB. Ciprofloxacin nephrotoxicity [letter]. Arch Intern Med 1993; 153: 2705–6CrossRefGoogle Scholar
  20. 20.
    Rippelmeyer DJ, Synmhavsky A. Ciprofloxacin and allergic interstitial nephritis. Ann Intern Med 1988; 109: 170PubMedGoogle Scholar
  21. 21.
    Boelaert J, de Jaegere PP, Daneels R, et al. Case report of renal failure during norfloxacin therapy [letter]. Clin Nephrol 1986; 25: 272PubMedGoogle Scholar
  22. 22.
    Allon M, Lopez EJ, Min K-W. Acute renal failure due to ciprofloxacin. Arch Int Med 1990; 150: 2187–9CrossRefGoogle Scholar
  23. 23.
    Raja N, Miller WE, McMillan R, et al. Ciprofloxacin-associated acute renal failure in patients undergoing high-dose chemotherapy and autologous stem cell rescue. Bone Marrow Transplant 1998; 21: 1283–4PubMedCrossRefGoogle Scholar
  24. 24.
    Rastogi S, Atkinson JLD, McCarthy JT. Allergic nephropathy associated with ciprofloxacin. Mayo Clin Proc 1990; 65: 987–9PubMedGoogle Scholar
  25. 25.
    Yew WW, Chau CH, Wong PC, et al. Ciprofloxacin induced renal dysfunction in patients with mycobacterial lung infections. Tubercle Lung Dis 1995; 76: 173–5CrossRefGoogle Scholar
  26. 26.
    Hadimeri H, Almroth G, Cederbrandt K, et al. Allergic nephrotoxicity associated with norfloxacin and ciprofloxacin therapy. Scand J Urol Nephrol 1997; 31: 481–5PubMedCrossRefGoogle Scholar
  27. 27.
    Arcieri G, August R, Becker N, et al. Clinical experience with ciprofloxacin in the USA. Eur J Clin Microbiol 1986; 5: 220–5PubMedCrossRefGoogle Scholar
  28. 28.
    Gerritsen WR, Peters A, Henny FC, et al. Ciprofloxacin-induced nephrotoxicity [letter]. Nephrol Dial Transplant 1987; 2: 382PubMedGoogle Scholar
  29. 29.
    Bailey JR, Trott SA, Philbrick JT. Ciprofloxacin-induced acute interstitial nephritis. Am J Nephrol 1992; 12: 271–3PubMedCrossRefGoogle Scholar
  30. 30.
    Thorsteinsson SB, Bergan T, Oddsdottir S, et al. Crystalluria and ciprofloxacin, influence of urinary pH and hydration. Chemotherapy 1986; 32: 408–17PubMedCrossRefGoogle Scholar
  31. 31.
    Inage F, Kato M, Yoshida M, et al. Lack of nephrotoxic effects of the new quinolone antibacterial agent levofloxacin in rabbits. Arzneimittelforschung 1992; 43(3A): 395–7PubMedGoogle Scholar
  32. 32.
    Lietman PS. Fluoroquinolone toxicities. An update. Drugs 1995; 49Suppl. 2: 159–63PubMedCrossRefGoogle Scholar
  33. 33.
    Blum MD, Graham DJ, McCloskey CA. Temafloxacin syndrome: review of 95 cases. Clin Infect Dis 1994; 18: 946–50PubMedCrossRefGoogle Scholar
  34. 34.
    Lipsky BA, Baker CA. Fluoroquinolone toxicity profiles: a review focusing on newer agents. Clin Infect Dis 1999; 28: 352–64PubMedCrossRefGoogle Scholar
  35. 35.
    Bourge RC. Invited letter concerning: acute interstitial nephritis in a cardiac transplant recipient receiving ciprofloxacin. J Thorac Cardiovasc Surg 1994; 107: 1364–79Google Scholar

Copyright information

© Adis International Limited 2000

Authors and Affiliations

  1. 1.Clinical Pharmacy Albany Medical Center HospitalAlbanyUSA

Personalised recommendations